Issue link: http://osercommunicationsgroup.uberflip.com/i/858130
Chain Drugstore Daily Monday, August 21, 2017 3 8 CLINICAL INTERVENTION SUITE DRIVES PHARMACY PROFITS Recent years have brought unprecedent- ed challenges to the practice of pharma- cy. Today, pharmacies are seeing lower profit-per-script from mushrooming generic use and lower margins from the proliferation of closed and limited net- works. In anticipation of these and other challenges, MarkeTouch Media has invested heavily in developing truly innovative technology solutions, expand- ing its platform from custom patient communications to become a full-service clinical provider. MarkeTouch Media's Clinical Intervention Suite is a robust, fully customizable engine that empowers pharmacists to have targeted clinical conversations with patients while eas- ing workflow burden on pharmacy staff. It includes multiple modules that enable client pharmacies to target and manage specific patient populations while maximizing contract incentives and minimizing penalties. MarkeTouch Media first analyzes the entire patient population, calculates PDC and a pro- prietary adherence score, notes whether immunizations or other serv- ices are needed, and then provides the list of clients to target for interven- tions, helping the pharmacy meet its contract objectives. Solutions targeted at DIR incentives focus on PDC scores across the entire Payor by drug class, while specialty pharmacy modules focus on patient assessments and data at intervals specific to each drug or dis- ease state. M a r k e To u c h 's staff applies industry- leading expertise and best practices to effectively deploy clinical programs designed to meet clients' goals and met- rics. In addition, MarkeTouch's capabili- ties and scale (a network of more than 15,000 retail pharmacies) enable it to readily run customized pilots for its clients, who can see for themselves the efficacy of the technology in driving down healthcare costs. For instance, MarkeTouch Adherence Interventions could increase PDC scores of targeted drug classes by more than 30 percent in 180 days by identifying and addressing barriers to adherence in retail pharmacy environments. MarkeTouch Media's RxTouch SM P h a r m a c i s t Connect is a fully hosted solution that streamlines phar- macy operations and allows each patient to choose preferred communi- cation channels for pharmacy interac- tion. By employing the patients' chan- nel preferences, the pharmacy can achieve greater adherence and persis- tency to the prescribed regimen. Each client can select campaigns that ensure targeted patients make a positive impact on quality and operational met- rics – resulting in a maximized ROI, reduced overall healthcare costs and ultimately, better clinical outcomes for patients. For more information, visit booth #1845 or go to www.rxtouch.com. UNDERSTANDING COGNITIVE HEALTH WITH FOCUSFACTOR An interview with Jack Ross, Chief Executive Officer, Synergy CHC Corp. CDD: Can you describe FOCUSfactor for our readers? JR: FOCUSfactor is a brain health sup- plement that contains a patented blend of vitamins, minerals, antioxidants and neuro-nutrients. In fact, FOCUSfactor packs so much nutrition into its patented formula, it could actually take the place of your current multi-vitamin. CDD: What makes FOCUSfactor unique in the brain health category? JR: Unlike most brain health supple- ments, FOCUSfactor has been clinically tested using a randomized, double-blind- ed, placebo-controlled study resulting in significant improvement in memory, con- centration and focus. FOCUSfactor has been America's No. 1 brain health sup- plement, having sold millions of bottles over the last 15 years. CDD: Who conducted the clinical study for FOCUSfactor and how was it differ- ent from other studies? JR: The study was conducted by Cognitive Research Corporation, a lead- ing clinical research organization in August of 2011 under the guidelines and protocol of the Institutional Review Board (IRB) with leading cognition experts overseeing the study. FOCUSfactor may have the first brand to actually conduct a cognitive assessment clinical study in a healthy population using a multi-ingredient formulation as opposed to a single ingredient study. CDD: Can you provide some insight into the clinical and some of the key findings? JR: The clinical set out to measure changes in memory, con- centration, attention and focus, which ran for a period of six weeks. The results showed that healthy adults who fol- lowed the study protocol showed significant improvement in memory, concentration and focus. The effects were particularly pronounced in what we call 'verbal learning and short-term memory.' Specifically, one of the test results showed a significant improvement in recall of 44 percent from 4.5 words (in the placebo group) versus 6.5 words (in the FOCUSfactor group). CDD: Is the brain health supplement cat- egory getting crowded? JR: The brain health category has grown by nearly 50 percent, which has led to a number of new products to enter the mar- ket. However, only FOCUSfactor has a patented formula that has shown signifi- cant improvement in memory, concentra- tion and focus in 3rd clinical trials. No other cognitive brand or product can make this claim or has had the long-term record of suc- cess. CDD: Can you tell our readers about your market- ing plans? JR: Our plans are to drive awareness and trial behind FOCUSfactor leveraging its unique set of cognitive benefits. We have entered into a multi- year licensing agreement to use Albert Einstein's name and likeness for our advertising campaign called 'Feed Your Einstein.' Specifically, we have devel- oped and run TV ads, print ads, social and digital ads and promotional/in-store merchandising, all leveraging this unique and impactful campaign. CDD: What's new for FOCUSfactor? JR: We have expanded the brand by launching a few new and innovative line extensions. The first new product is FOCUSfactor Extra Strength, which provides an advanced formulation with increased levels of key selected neuro- nutrients. FOCUSfactor Brain & Vision combines the original formula with clinically tested levels of Lutein and Zeaxanthin for improved eye-support, creating a 2-in-1 formula. FOCUSfactor for Kids has been specif- ically designed for kids with vitamins and neuro-nutrients to help support healthy brain function. The product comes in a great tasting berry blast chewable and contains no artificial col- ors, flavors or preservatives and is gluten- and dairy-free. CDD: What are your thoughts on the future of the brain health category? JR: The category is poised to continue its double-digit growth over the next three to five years. All the trends indicate that brain health will grow to similar levels as the eye health and joint health categories, with FOCUSfactor leading the way in providing nutrition for the brain. For more information, visit booth #1449. Sales inquiries should contact Al Baumeler at 561.383.1102 or via email at al@synergychc.com.